This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has begun to perform antibody testing for coronavirus (COVID-19) using blood...
SOUTH SAN FRANCISCO, Calif., April 09, 2020 -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report first quarter 2020 results on Wednesday, April 22, 2020,...
Through its "Peace of Mind" program, Quest Diagnostics (NYSE: DGX) is taking extra measures to ensure individuals who are the most vulnerable to adverse COVID-19 outcomes have special VIP-level...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors has elected Mr. Wright L. Lassiter III to serve as a...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it will launch a coronavirus (COVID-19) test service. The new test service aids the...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Barclays Global Healthcare Conference in...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the fourth quarter and full year ended December...
Quest Diagnostics (NYSE: DGX), the leading provider of diagnostic information services, and Memorial Hermann Health System, a leading not-for-profit health system that includes 17 hospitals and...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has acquired Blueprint Genetics in an all-cash equity transaction. Blueprint...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has been selected as one of FORTUNE's World's Most Admired Companies in 2020...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report fourth quarter and full year 2019 results on Thursday,...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the 38th Annual J. P. Morgan Healthcare...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today the pricing of a public offering of $800 million aggregate principal...
Quest Diagnostics Acquires the Clinical Laboratory Services of Boston Clinical Laboratories in Massachusetts SECAUCUS, N.J. -- December 2, 2019 — Quest Diagnostics (NYSE:DGX), the world’s...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.53 per share,...
A laboratory test that evaluates high-density lipoprotein (HDL) cholesterol function provides unique and novel information for assessing cardiovascular disease risk, according to data presented...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has achieved Gold status in the American Heart Association's 2019 Workplace...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the third quarter ended September 30, 2019. "We...
Most primary care physicians (62%) fear the opioid drug crisis will be traded for a new prescription drug crisis and nearly three quarters (72%) worry that chronic pain patients will turn to...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report third quarter 2019 results on Tuesday, October 22, 2019,...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has received the 2019 Best Employers: Excellence in Health & Well-Being...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and hc1, the bioinformatics leader in precision testing, today unveiled Quest® Lab Stewardship™...
One third of U.S. industry sectors experienced year-over-year double-digit increases in workforce drug positivity between 2015 and 2018, according to a new analysis of industry-specific data by...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that Manuel O. Méndez has been named Senior Vice President and Chief Commercial...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Morgan Stanley Global Healthcare...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Baird 2019 Global Healthcare Conference...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.53 per share,...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the second quarter ended June 30, 2019. "Our...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today the expansion of the Global Diagnostics Network (GDN), a strategic working group of...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has been named to the 2019 Disability Equality Index (DEI) "Best Places to Work...
Catholic Health Services (CHS), an integrated health care delivery system with a 24% market share on Long Island, is teaming up with Quest Diagnostics (NYSE: DGX), the world's leading provider of...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report second quarter 2019 results on Tuesday, July 23, 2019,...
SECAUCUS, NJ, July 9, 2019 -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today launched a new Lyme Disease test offering that individuals can...
SECAUCUS, N.J. and EDEN PRAIRIE, Minn. (July 9, 2019) – As recently reported in numerous media outlets, on May 14, 2019, Retrieval-Masters Creditors Bureau, Inc./American Medical Collection...
Individuals with prediabetes who participate in an employer-sponsored digital diabetes-prevention counseling program may reduce their risk of developing type 2 diabetes (T2D) for up to eight...
American Medical Collection Agency (AMCA), a collection agency, has disclosed that an unauthorized user had access to AMCA’s system between August 1, 2018, and March 30, 2019.
American Medical Collection Agency (AMCA), a billing collections service provider, has informed Quest Diagnostics that an unauthorized user had access to AMCA’s system containing personal...
Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced it is participating as a designated laboratory in the NCI-Molecular Analysis for Therapy...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.53 per share,...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the UBS Global Healthcare Conference in New...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the first quarter ended March 31, 2019. "We're...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it was selected by Forbes as one of America's Best Large Employers...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today launched three new sexually transmitted disease (STD) laboratory test packages that...
The rate of workforce drug positivity hit a fourteen-year high in 2018, according to a new analysis released today by Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report first quarter 2019 results on Tuesday, April 23, 2019,...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today awarded Supplier Excellence awards to four companies at its 2019 Supplier Forum. Supplier...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, received a perfect score of 100 from the Human Rights Campaign Foundation on the 2019...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, hosted Massachusetts Governor Charlie Baker at its state-of-the-art clinical testing laboratory in...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it will present results of eight studies at the 2019 American College of...